Replies to post #209579 on Elite Pharmaceuticals Inc (ELTP)

[Hike]

So you disagree with the IMS figures that state IR in 2014 was 88.7% of the market?

The IMS will be very upset someone is questioning their stats.

[rrr2003]

That's funny. The pie chart which is at the center of this debate shows IR (immediate release) prescriptions are overwhelmingly prescribed over the ER (extended release) scripts. The supplemental information provided by Hike confirms the chart data without a doubt. And yet you have not provided anything factual that would contest the data shown in the graph. If you have anything that can show IR opiod scripts are not predominently prescribed then provide it.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123722661